In agreement, ANRIL positively acts on HDR by modulating the miR-7-5p/PARP1/RAD51 and miR-145-5p/MMP1 pathways in LC and TNBC respectively [100,228]. This evidence concerns the gene CDKN2B-AS1 and laryngotracheoesophageal cleft.